Maitreya Medicare Limited — PPTs, 08-09-2025: Investor Presentation

Maitreya Medicare's FY25 revenue reached ₹46.66 Cr (down from ₹47.80 Cr in FY24), with PAT at ₹1.87 Cr (down from ₹2.66 Cr). This was driven by significant short-term costs from aggressive expansion in Gujarat & Maharashtra, as per management. Core specialties like Cardiology & Neurosurgery remain major revenue contributors.

The growth strategy focuses on expanding its hospital network for better accessibility, aiming for 100% bed utilization from current ~50% capacity next year. Recent milestones include partnerships with Prannath Hospital (Surat) and Vinish Healthcare (Nandurbar), plus new cath lab installations. Plans include expanding elderly care via Tulip and launching oncology/radiotherapy at Prannath.

The new 125-bed Valsad hospital is set for Oct 2025. Maitreya also achieved NABH accreditation for Digital Health Standards. FY25 EBITDA stood at ₹3.37 Cr.